Showing 581-600 of 8668 for: Cochrane Systematic Reviews Back
- Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Cochrane Systematic Reviews, 13-May-2008
Venous thromboembolism (VTE) is the term given to any thromboembolic event (blocking of a blood vessel by a blood clot) occurring in the venous system. The current treatment recommended for VTE is anticoagulation (reduction of the blood's ability to clot)
- Anticoagulation for cerebral venous sinus thrombosis
Cochrane Systematic Reviews, 10-Aug-2011
Treatment of cerebral venous sinus thrombosis with anticoagulants has been controversial. Anticoagulants may prevent new venous infarcts, neurologic deterioration and pulmonary embolism but may also promote haemorrhages.
- Anticoagulation for people with cancer and central venous catheters
Cochrane Systematic Reviews, 1-Jun-2018
Central venous catheter (CVC) placement increases the risk of thrombosis in people with cancer. Thrombosis often necessitates the removal of the CVC, resulting in treatment delays and thrombosis-related morbidity and mortality. This is an update of the Co
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
Cochrane Systematic Reviews, 11-Jul-2018
The choice of the appropriate perioperative thromboprophylaxis for people with cancer depends on the relative benefits and harms of different anticoagulants.
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
Cochrane Systematic Reviews, 8-Dec-2021
Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop recurrent VTE.
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
Cochrane Systematic Reviews, 19-Jun-2018
Cancer increases the risk of thromboembolic events, especially in people receiving anticoagulation treatments.
- Anticoagulation therapy versus placebo for pulmonary hypertension
Cochrane Systematic Reviews, 2-Jun-2014
Elevation of pulmonary pressure is no longer a rare disease, given its multifactorial etiology. However data on the actual incidence of this condition are still limited, and controversies regarding its management are ongoing. Use of anticoagulation in the
- Anticoagulation versus placebo for heart failure in sinus rhythm
Cochrane Systematic Reviews, 18-May-2021
People with chronic heart failure (HF) are at risk of thromboembolic events, including stroke, pulmonary embolism, and peripheral arterial embolism; coronary ischaemic events also contribute to the progression of HF. The use of long-term oral anticoagulat
- Anticonvulsant drugs for acute and chronic pain
Cochrane Systematic Reviews, 3-Sep-2009
Anticonvulsant drugs have been used in the management of pain since the 1960s. The clinical impression is that they are useful for chronic neuropathic pain, especially when the pain is lancinating or burning. Readers are referred to reviews of carbamazepi
- Anticonvulsant drugs for migraine prophylaxis
Cochrane Systematic Reviews, 27-May-2016
This review has been split and updated in a series of four new reviews, all with the author byline Linde M, Mulleners WM, Chronicle EP, McCrory DC. The new titles are:
- Anticonvulsant therapy for status epilepticus
Cochrane Systematic Reviews, 10-Sep-2014
Status epilepticus is a medical emergency associated with significant mortality and morbidity that requires immediate and effective treatment.
- Anticonvulsants for alcohol dependence
Cochrane Systematic Reviews, 12-Feb-2014
Alcohol dependence is a major public health problem that is characterised by recidivism and a host of medical and psychosocial complications. Besides psychosocial interventions, different pharmacological interventions have been or currently are under inve
- Anticonvulsants for alcohol withdrawal
Cochrane Systematic Reviews, 17-Mar-2010
Alcohol abuse and dependence represents a most serious health problem worldwide with major social, interpersonal and legal interpolations. Besides benzodiazepines, anticonvulsants are often used for the treatment of alcohol withdrawal symptoms. Anticonvul
- Anticonvulsants for cocaine dependence
Cochrane Systematic Reviews, 17-Apr-2015
Cocaine dependence is a major public health problem that is characterised by recidivism and a host of medical and psychosocial complications. Although effective pharmacotherapy is available for alcohol and heroin dependence, none is currently available fo
- Anticonvulsants for fibromyalgia
Cochrane Systematic Reviews, 9-Oct-2017
Fibromyalgia (FM) is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue. People often report high disability levels and poor health-related quality
- Anticonvulsants for neonates with seizures
Cochrane Systematic Reviews, 11-Nov-2008
Neonatal seizures are a common problem and most neonates with seizures are treated with anticonvulsants. There is wide variation in clinical practice in both diagnosis and treatment of such seizures and this reflects the lack of clear evidence of the rela
- Anticonvulsants for preventing seizures in patients with chronic subdural haematoma
Cochrane Systematic Reviews, 6-Jun-2013
Anticonvulsant therapy is sometimes used prophylactically in patients with chronic subdural haematoma, although the benefit is unclear.
- Anticonvulsants for tinnitus
Cochrane Systematic Reviews, 9-Jun-2011
Tinnitus is the perception of sound or noise in the absence of an external or internal acoustic stimulation. It is a common and potentially distressing symptom for which no adequate therapy exists.
- Anti‐cytokine targeted therapies for ANCA‐associated vasculitis
Cochrane Systematic Reviews, 29-Sep-2020
Anti-neutrophilic cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) are a group of rare auto-inflammatory diseases that affects mainly small vessels. AAV includes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinoph
- Anti‐D administration after childbirth for preventing Rhesus alloimmunisation
Cochrane Systematic Reviews, 21-Apr-1997
The development of Rhesus immunisation and its prophylactic use since the 1970s has meant that severe Rhesus D (RhD) alloimmunisation is now rarely seen.
